Talk to the Institute
Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Lyell Immunopharma, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/lyell-immunopharma-inc

Lyell Immunopharma, Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: LYEL
Verification
Partially verified
Last reviewed
2026-10-16T13:52:54.339891+00:00

Overview

Alpha's canonical identity and public leadership record for Lyell Immunopharma, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

6 public records

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

8 public records

Committees

3 public records

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

Audit

Chair
William Rieflin
Members
William Rieflin (Chair); Clifford J. Friedman; Elizabeth Nabel

Compensation

Chair
Clifford J. Friedman
Members
Clifford J. Friedman (Chair); William Rieflin

Nominating and Governance

Chair
Not stated
Members
Elizabeth Nabel

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-16T13:52:54.339891+00:00

Generated 2026-10-17T03:38:16.165Z

Data as of 2026-10-16T13:52:54.339891+00:00

https://registry.alpha.ac/companies/lyell-immunopharma-inc